“Buprenorphine + Naloxone plus Naltrexone for the Treatment of Cocaine Dependence: The Cocaine Use Reduction with Buprenorphine (CURB) Study”, Addiction, vol. 111, no. 6, pp. 1416-1427, 2016.
, “Opioid, NSAID, and OTC Analgesic Medications for Dental Procedures: PEARL Network Findings”, Compend Contin Educ Dent, vol. 37, no. 10, pp. 710-718, 2016.
, “Participant Treatment Assignment Perceptions in the NIDA CTN Cocaine Use Reduction with Buprenorphine Study”, in 2016 CPDD Scientific Meeting, Palm Springs, CA, 2016.
, “Internet-Delivered Treatment for Substance Abuse: A Multisite Randomized Controlled Trial”, Am J Psychiatry, vol. 171, pp. 683-690, 2014.
, “Periodontal Diagnosis Affected by Variation in Terminology”, J Periodontol, vol. 84, pp. 606-613, 2013.
, “Treatments for Hypersensitive Noncarious Cervical Lesions: A Practitioners Engaged in Applied Research and Learning (PEARL) Network Randomized Clinical Effectiveness Study”, J Am Dent Assoc, vol. 144, pp. 495-506, 2013.
, “ABO-Blood Groups and Risk of Abdominal Aortic Aneurysm and Peripheral Obstructive Artery Disease: Two Sides of the Same Coin”, Thromb Res, vol. 129, no. 129, pp. 89-90, 2012.
, “An Assessment of the Perceived Benefits and Challenges of Participating in a Practice-based Research Network”, Prim Dent J, vol. 1, pp. 50-57, 2012.
, “Dentin Caries Activity in Early Occlusal Lesions Selected to Receive Operative Treatment: Findings from the Practitioners Engaged in Applied Research and Learning (PEARL) Network”, J Am Dent Assoc, vol. 143, pp. 377-385, 2012.
, “Level of Oral Health Impacts Among Patients Participating in PEARL: A Dental Practice-Based Research Network”, Community Dent Oral Epidemiol, vol. 40, no. 4, pp. 332-342, 2012.
, “Comparison of Six Statistics of Genetic Association Regarding Their Ability to Discriminate Between Causal Variants and Genetically Linked Markers”, Hum Hered, vol. 72, pp. 142-152, 2011.
,